Themis Medicare Limited (THEMISMED) — Announcement | 17 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company updates registered email addresses for investor communications
💡 Investor Takeaway
Shareholders must use the new email addresses for all official communications and filings.

Themis Medicare Limited updated its official email addresses for corporate correspondence and registrar transfer activities, replacing sangameshwar.iyer@themismedicare.com with suresh.savaliya@themismedicare.com and updating the RTA contact to investor.helpdesk@in.mpms.mufg.com, effective immediately for all future investor communications.

📄 View Original Announcement (PDF)

About Themis Medicare Limited (THEMISMED)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,142.96 Cr P/E: 28.6 ROE: 9.9% ROCE: 13.6% Div Yield: 0.40%

View full THEMISMED stock details →

📡 Get AI alerts when THEMISMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THEMISMED — Free

📊 More THEMISMED filings

See all THEMISMED filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THEMISMED files new disclosures

Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THEMISMED — Free

Free account · 2 AI queries/day